Federated Hermes, Inc. Praxis Precision Medicines, Inc. Transaction History

Federated Hermes, Inc.

  • $42.5 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.83 - $1.18 $18,323 - $26,050
-22,077 Reduced 5.69%
365,690 $420,000
Q1 2023

May 08, 2023
BUY
$0.8 - $4.98 $15,469 - $96,298
19,337 Added 5.25%
387,767 $314,000
Q4 2022

Feb 13, 2023
BUY
$1.88 - $2.49 $535,711 - $709,532
284,953 Added 341.36%
368,430 $876,000
Q3 2022

Nov 14, 2022
BUY
$2.5 - $4.77 $208,692 - $398,185
83,477 New
83,477 $189,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0
View Full List

About Praxis Precision Medicines, Inc.

PRAX Quotes by TradingView
  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $1.84B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email